Nature, nurture and HIV: The effect of producer cell on viral physiology

Virology

Volumn 443, Issue 2, 2013, Pages 208-213

  Iordanskiy, Sergey ^a,b   Santos, Steven ^a   Bukrinsky, Michael ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

HIV 1; Macrophages; T lymphocytes; Viral replication; Virion incorporated lipids; Virion incorporated proteins

Indexed keywords

ABC TRANSPORTER A1; B7 ANTIGEN; CD63 ANTIGEN; CD81 ANTIGEN; CD82 ANTIGEN; CD86 ANTIGEN; CD9 ANTIGEN; CELL PROTEIN; CHAPERONE; GAG PROTEIN; HLA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIPOCORTIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; RNA HELICASE; URACIL DNA GLYCOSIDASE;

CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CHOLESTEROL TRANSPORT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; VIRAL PHENOMENA AND FUNCTIONS; VIRION; VIRUS ASSEMBLY; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION;

HIV-1; MACROPHAGES; T LYMPHOCYTES; VIRAL REPLICATION; VIRION-INCORPORATED LIPIDS; VIRION-INCORPORATED PROTEINS;

CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; VIRION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84880510399     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.023     Document Type: Short Survey

References (95)

1. Accola M.A., Strack B., Gottlinger H.G. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J. Virol. 2000, 74:5395-5402.
2. Ajamian L., Abrahamyan L., Milev M., Ivanov P.V., Kulozik A.E., Gehring N.H., Mouland A.J. Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 2008, 14:914-927.
3. Arjan-Odedra S., Swanson C.M., Sherer N.M., Wolinsky S.M., Malim M.H. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses. Retrovirology 2012, 9:53.
4. Bennett A.E., Narayan K., Shi D., Hartnell L.M., Gousset K., He H., Lowekamp B.C., Yoo T.S., Bliss D., Freed E.O., Subramaniam S. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog. 2009, 5:e1000591.
5. Bergamaschi A., Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010, 7:31.
6. Bolinger C., Sharma A., Singh D., Yu L., Boris-Lawrie K. RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38:1686-1696.
7. Bregnard C., Zamborlini A., Leduc M., Chafey P., Camoin L., Saib A., Benichou S., Danos O., Basmaciogullari S. Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol. 2013, 87:3729-3740.
8. Bukong T.N., Hall W.W., Jacque J.M. Lentivirus-associated MAPK/ERK2 phosphorylates EMD and regulates infectivity. J. Gen. Virol. 2010, 91:2381-2392.
9. Burdick R., Smith J.L., Chaipan C., Friew Y., Chen J., Venkatachari N.J., viks-Frankenberry K.A., Hu W.S., Pathak V.K. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J. Virol. 2010, 84:10241-10253.
10. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 1997, 90:1091-1100.
11. Cantin R., Fortin J.F., Lamontagne G., Tremblay M. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 1997, 71:1922-1930.
12. Cantin R., Methot S., Tremblay M.J. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J. Virol. 2005, 79:6577-6587.
13. Carter C.C., Onafuwa-Nuga A., McNamara L.A., Riddell J., Bixby D., Savona M.R., Collins K.L. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat. Med. 2010, 16:446-451.
14. Chatel-Chaix L., Abrahamyan L., Frechina C., Mouland A.J., DesGroseillers L. The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization. J. Virol. 2007, 81:6216-6230.
15. Chatel-Chaix L., Boulay K., Mouland A.J., DesGroseillers L. The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminus. Retrovirology 2008, 5:41.
16. Chen R., Le Rouzic E., Kearney J.A., Mansky L.M., Benichou S. Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate the virus mutation rate and for replication in macrophages. J. Biol. Chem. 2004, 279:28419-28425.
17. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80:9039-9052.
18. Christensen H.S., Daher A., Soye K.J., Frankel L.B., Alexander M.R., Laine S., Bannwarth S., Ong C.L., Chung S.W., Campbell S.M., Purcell D.F., Gatignol A. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J. Virol. 2007, 81:5121-5131.
19. Churchill M.J., Wesselingh S.L., Cowley D., Pardo C.A., McArthur J.C., Brew B.J., Gorry P.R. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 2009, 66:253-258.
20. Cosma A., Blanc D., Braun J., Quillent C., Barassi C., Moog C., Klasen S., Spire B., Scarlatti G., Pesenti E., Siccardi A.G., Beretta A. Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. AIDS 1999, 13:2033-2042.
21. Cui H.L., Grant A., Mukhamedova N., Pushkarsky T., Jennelle L., Dubrovsky L., Gaus K., Fitzgerald M.L., Sviridov D., Bukrinsky M. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J. Lipid Res. 2012, 53:696-708.
22. Davis D.A., Newcomb F.M., Starke D.W., Ott D.E., Mieyal J.J., Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J. Biol. Chem. 1997, 272:25935-25940.
23. De Maria A., Pantaleo G., Schnittman S.M., Greenhouse J.J., Baseler M., Orenstein J.M., Fauci A.S. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. J. Immunol. 1991, 146:2220-2226.
24. Demirov D.G., Orenstein J.M., Freed E.O. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 2002, 76:105-117.
25. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J. Cell Biol. 2007, 177:329-341.
26. Duncan C.J., Sattentau Q.J. Viral determinants of HIV-1 macrophage tropism. Viruses 2011, 3:2255-2279.
27. Finzi A., Orthwein A., Mercier J., Cohen E.A. Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 2007, 81:7476-7490.
28. Fortin J.F., Cantin R., Lamontagne G., Tremblay M. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 1997, 71:3588-3596.
29. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107:55-65.
30. Gorry P.R., Ancuta P. Coreceptors and HIV-1 pathogenesis. Curr. HIV/AIDS Rep. 2011, 8:45-53.
31. Gousset K., Ablan S.D., Coren L.V., Ono A., Soheilian F., Nagashima K., Ott D.E., Freed E.O. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 2008, 4:e1000015.
32. Guenzel C.A., Herate C., Le R.E., Maidou-Peindara P., Sadler H.A., Rouyez M.C., Mansky L.M., Benichou S. Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1. J. Virol. 2012, 86:2533-2544.
33. Gurer C., Cimarelli A., Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J. Virol. 2002, 76:4666-4670.
34. Jacque J.M., Mann A., Enslen H., Sharova N., Brichacek B., Davis R.J., Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 1998, 17:2607-2618.
35. Jeanson L., Subra F., Vaganay S., Hervy M., Marangoni E., Bourhis J., Mouscadet J.F. Effect of Ku80 depletion on the preintegrative steps of HIV-1 replication in human cells. Virology 2002, 300:100-108.
36. Jones K.L., Roche M., Gantier M.P., Begum N.A., Honjo T., Caradonna S., Williams B.R., Mak J. X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells. J. Biol. Chem. 2010, 285:18603-18614.
37. Jouve M., Sol-Foulon N., Watson S., Schwartz O., Benaroch P. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell Host Microbe 2007, 2:85-95.
38. Jouvenet N., Neil S.J., Bess C., Johnson M.C., Virgen C.A., Simon S.M., Bieniasz P.D. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 2006, 4:e435.
39. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 2008, 105:7552-7557.
40. Kolegraff K., Bostik P., Ansari A.A. Characterization and role of lentivirus-associated host proteins. Exp. Biol. Med. (Maywood) 2006, 231:252-263.
41. Krementsov D.N., Weng J., Lambele M., Roy N.H., Thali M. Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology 2009, 6:64-66.
42. Langhoff E., Haseltine W.A. Infection of accessory dendritic cells by human immunodeficiency virus type 1. J. Invest. Dermatol. 1992, 99:89S-94S.
43. Langhoff E., Terwilliger E.F., Bos H.J., Kalland K.H., Poznansky M.C., Bacon O.M., Haseltine W.A. Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc. Natl. Acad. Sci. USA 1991, 88:7998-8002.
44. Li L., Olvera J.M., Yoder K.E., Mitchell R.S., Butler S.L., Lieber M., Martin S.L., Bushman F.D. Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J. 2001, 20:3272-3281.
45. Liu J., Henao-Mejia J., Liu H., Zhao Y., He J.J. Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. J. Neuroimmune Pharmacol. 2011, 6:308-321.
46. Lorgeoux R.P., Guo F., Liang C. From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication. Retrovirology 2012, 9:79.
47. Lunardi-Iskandar Y., Nugeyre M.T., Georgoulias V., Barre-Sinoussi F., Jasmin C., Chermann J.C. Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. J. Clin. Invest. 1989, 83:610-615.
48. Ma G., Greenwell-Wild T., Lei K., Jin W., Swisher J., Hardegen N., Wild C.T., Wahl S.M. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J. Exp. Med. 2004, 200:1337-1346.
49. Malim M.H., Bieniasz P.D. HIV restriction factors and mechanisms of evasion. Cold Spring Harb. Perspect. Med. 2012, 2:a006940.
50. Martin-Serrano J., Neil S.J. Host factors involved in retroviral budding and release. Nat. Rev. Microbiol. 2011, 9:519-531.
51. Martin-Serrano J., Zang T., Bieniasz P.D. Role of ESCRT-I in retroviral budding. J. Virol. 2003, 77:4794-4804.
52. Meng B., Lever A.M. Wrapping up the bad news-HIV assembly and release. Retrovirology 2013, 10:5.
53. Monte D., Groux H., Raharinivo B., Plouvier B., Dewulf J., Clavel T., Grangette C., Torpier G., Auriault C., Capron A., Ameisen J.-C. Productive human immunodeficiency virus-1 infection of megakaryocytic cells is enhanced by tumor necrosis factor-alpha. Blood 1992, 79:2670-2679.
54. Morrow M.P., Grant A., Mujawar Z., Dubrovsky L., Pushkarsky T., Kiselyeva Y., Jennelle L., Mukhamedova N., Remaley A.T., Kashanchi F., Sviridov D., Bukrinsky M. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol. Pharmacol. 2010, 78:215-225.
55. Moses A.V., Bloom F.E., Pauza C.D., Nelson J.A. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA 1993, 90:10474-10478.
56. Mosier D.E. Virus and target cell evolution in human immunodeficiency virus type 1 infection. Immunol. Res. 2000, 21:253-258.
57. Mujawar Z., Rose H., Morrow M.P., Pushkarsky T., Dubrovsky L., Mukhamedova N., Fu Y., Dart A., Orenstein J.M., Bobryshev Y.V., Bukrinsky M., Sviridov D. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006, 4:e365.
58. Mulky A., Cohen T.V., Kozlov S.V., Korbei B., Foisner R., Stewart C.L., Kewalramani V.N. The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections. J. Virol. 2008, 82:5860-5868.
59. Nguyen D.G., Booth A., Gould S.J., Hildreth J.E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 2003, 278:52347-52354.
60. Ono A. HIV-1 assembly at the plasma membrane: gag trafficking and localization. Future Virol. 2009, 4:241-257.
61. Ono A., Freed E.O. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 2004, 78:1552-1563.
62. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 2003, 162:443-455.
63. Perez-Caballero D., Hatziioannou T., Martin-Serrano J., Bieniasz P.D. Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J. Virol. 2004, 78:9560-9563.
64. Perugi F., Muriaux D., Ramirez B.C., Chabani S., Decroly E., Darlix J.L., Blot V., Pique C. Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity. Mol. Biol. Cell 2009, 20:498-508.
65. Priet S., Navarro J.M., Gros N., Querat G., Sire J. Functional role of HIV-1 virion-associated uracil DNA glycosylase 2 in the correction of G:U mispairs to G:C pairs. J. Biol. Chem. 2003, 278:4566-4571.
66. Pushkarsky T., Zybarth G., Dubrovsky L., Yurchenko V., Tang H., Guo H., Toole B., Sherry B., Bukrinsky M. CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proc. Natl. Acad. Sci. USA 2001, 98:6360-6365.
67. Rai T., Mosoian A., Resh M.D. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J. Virol. 2010, 84:9783-9792.
68. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., Geuze H. Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 2002, 3:718-729.
69. Roy B.B., Hu J., Guo X., Russell R.S., Guo F., Kleiman L., Liang C. Association of RNA helicase a with human immunodeficiency virus type 1 particles. J. Biol. Chem. 2006, 281:12625-12635.
70. Ryzhova E.V., Vos R.M., Albright A.V., Harrist A.V., Harvey T., Gonzalez-Scarano F. Annexin 2: a novel human immunodeficiency virus type 1 gag binding protein involved in replication in monocyte-derived macrophages. J. Virol. 2006, 80:2694-2704.
71. Saini M., Potash M.J. Novel activities of cyclophilin A and cyclosporin A during HIV-1 infection of primary lymphocytes and macrophages. J. Immunol. 2006, 177:443-449.
72. Santos S., Obukhov Y., Nekhai S., Bukrinsky M., Iordanskiy S. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9:65.
73. Sato K., Aoki J., Misawa N., Daikoku E., Sano K., Tanaka Y., Koyanagi Y. Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins. J. Virol. 2008, 82:1021-1033.
74. Schaller T., Ocwieja K.E., Rasaiyaah J., Price A.J., Brady T.L., Roth S.L., Hue S., Fletcher A.J., Lee K., Kewalramani V.N., Noursadeghi M., Jenner R.G., James L.C., Bushman F.D., Towers G.J. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011, 7:e1002439.
75. Schmidtmayerova H., Alfano M., Nuovo G., Bukrinsky M. Human immunodeficiency virus type 1T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 1998, 72:4633-4642.
76. Sokolskaja E., Sayah D.M., Luban J. Target cell cyclophilin a modulates human immunodeficiency virus type 1 infectivity. J. Virol. 2004, 78:12800-12808.
77. Sorin M., Cano J., Das S., Mathew S., Wu X., Davies K.P., Shi X., Cheng S.W., Ott D., Kalpana G.V. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. PLoS Pathog. 2009, 5:e1000463.
78. Steffan A.M., Lafon M.E., Gendrault J.L., Schweitzer C., Royer C., Jaeck D., Arnaud J.P., Schmitt M.P., Aubertin A.M., Kirn A. Primary cultures of endothelial cells from the human liver sinusoid are permissive for human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 1992, 89:1582-1586.
79. Stephenson S.T., Bostik P., Song B., Rajan D., Bhimani S., Rehulka P., Mayne A.E., Ansari A.A. Distinct host cell proteins incorporated by SIV replicating in CD4+ T cells from natural disease resistant versus non-natural disease susceptible hosts. Retrovirology 2010, 7:107.
80. Thali M. The roles of tetraspanins in HIV-1 replication. Curr. Top. Microbiol. Immunol. 2009, 339:85-102.
81. Thali M. Tetraspanin functions during HIV-1 and influenza virus replication. Biochem. Soc. Trans. 2011, 39:529-531.
82. Tsubota H., Ringler D.J., Kannagi M., King N.W., Solomon K.R., MacKey J.J., Walsh D.G., Letvin N.L. CD8+CD4- lymphocyte lines can harbor the AIDS virus in vitro. J. Immunol. 1989, 143:858-863.
83. Verani A., Pesenti E., Polo S., Tresoldi E., Scarlatti G., Lusso P., Siccardi A.G., Vercelli D. CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J. Immunol. 1998, 161:2084-2088.
84. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., Sundquist W.I. The protein network of HIV budding. Cell 2003, 114:701-713.
85. Wahl S.M., Greenwell-Wild T., Vazquez N. HIV accomplices and adversaries in macrophage infection. J. Leukoc. Biol. 2006, 80:973-983.
86. Weiss E.R., Gottlinger H. The role of cellular factors in promoting HIV budding. J. Mol. Biol. 2011, 410:525-533.
87. Welsch S., Keppler O.T., Habermann A., Allespach I., Krijnse-Locker J., Krausslich H.G. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007, 3:e36.
88. Weng J., Krementsov D.N., Khurana S., Roy N.H., Thali M. Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells. J. Virol. 2009, 83:7467-7474.
89. Willetts K.E., Rey F., Agostini I., Navarro J.M., Baudat Y., Vigne R., Sire J. DNA repair enzyme uracil DNA glycosylase is specifically incorporated into human immunodeficiency virus type 1 viral particles through a Vpr-independent mechanism. J. Virol. 1999, 73:1682-1688.
90. Xing L., Liang C., Kleiman L. Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J. Virol. 2011, 85:1847-1860.
91. Yedavalli V.S., Neuveut C., Chi Y.H., Kleiman L., Jeang K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
92. Yi Y., Rana S., Turner J.D., Gaddis N., Collman R.G. CXCR-4 is expressed by primary macrophages and supports CCR5- independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J. Virol. 1998, 72:772-777.
93. Yung E., Sorin M., Wang E.J., Perumal S., Ott D., Kalpana G.V. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance. J. Virol. 2004, 78:2222-2231.
94. Zaitseva M., Blauvelt A., Lee S., Lapham C.K., Klaus-Kovtun V., Mostowski H., Manischewitz J., Golding H. Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat. Med. 1997, 3:1369-1375.
95. Zhang F., Zang T., Wilson S.J., Johnson M.C., Bieniasz P.D. Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog. 2011, 7:e1002119.